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A number of values for the MCID based on distribution-based statistical methods
36
(i.e.,methods that compare change scores to a measure of variability) 1 
46
In this paper, we estimate-from multiple perspectives using both statistical and anchored methods-the value of the MCID for a measure based on the Neuropsychiatric
48
Inventory (NPI) subscales for irritability and aggression among individuals with traumatic brain 49 injury (TBI). The NPI was originally designed for administration as a structured interview for 50 assessing neuropsychiatric syndromes with scoring based on the most problematic item on each 51 subscale. 6 We have developed a measure, the Rasch Neuropsychiatric Inventory Irritability and M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
Rasch NPI-TBI-IA MCID Global Impression of Change scores provided by the participant, an observer, and a physician.
70
Participants in all studies had a history of moderate-severe TBI and were at least 6 months post- scores were missing; GIC data were also missing for these cases. Because of the small number 106 of missing data, imputation was not attempted.
107

Results
108
Values for distribution-based indicators for both participant and observer ratings are shift toward greater endorsement of "much" and "very much" general improvement at the 1 SD M A N U S C R I P T M A N U S C R I P T M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
Highlights
• A measure combining the Irritability/Lability and Agitation/Aggression subscales of the Neuropsychiatric Inventory (NPI-TBI-IA) has been developed for use with individuals with traumatic brain injury (TBI).
• The new measure (the Rasch Neuropsychiatric Inventory Irritability and Aggression Scale for TBI; NPI-TBI-IA) was developed with Rasch analysis and includes responses to all specific items on these subscales.
• The Minimal Clinically Important Difference (MCID) is the smallest change on a clinical measure that is associated with a meaningful perceived difference in an individual's condition, function, or quality of life.
• We determined the MCID for this measure using distribution-based and by anchoring the measure to Global Impression of Change scales completed by individuals with TBI, their observers, and their physicians.
• Our analysis suggests that the MCID for the NPI-TBI-IA is ½ standard deviation and that a standard deviation change indicates a Robust Clinically Important Difference for both observer ratings and participant self-ratings.
